Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968005 · ClinicalTrials.gov registry record · Phase 3
Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain
A Phase 3 study, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 232
- Enrollment target
NCT01968005: Completed Phase 3 study, sponsored by MEDRx USA.
NCT01968005 is a Phase 3 study that has completed, run by MEDRx USA. The registered enrollment target is 232 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01968005, a Phase 3 study, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 232 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).
Interventions
- DRUG Placebo
- DRUG Etoreat®(Etodolac-Lidocaine Topical Patch)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-11 |
| Phase | Phase 3 |
What the finished NCT01968005 record still lists
NCT01968005 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01968005 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01968005 about?
NCT01968005 is a clinical study titled "Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain". The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).
What is the current status of trial NCT01968005?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 232 participants. The study started on 2013-11. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01968005?
The interventions under investigation include: Placebo (DRUG), Etoreat®(Etodolac-Lidocaine Topical Patch) (DRUG).
Who is sponsoring clinical trial NCT01968005?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01968005's enrollment target sits among peer trials
232 1298th of 2000 higher than 701 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia